Sinovac Biotech Ltd (SVA) — Strategic Asset Allocation Index
Sinovac Biotech Ltd (SVA) has a Strategic Asset Allocation Index of 5.9% as of June 2024. Strategic assets (PP&E of $- plus long-term investments of $681.35 Million) total $681.35 Million, measured against net assets of $11.51 Billion. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base.
SAAI
Strategic Assets
PP&E
Net Assets
Sinovac Biotech Ltd Strategic Asset Allocation Index (2002–2023)
This chart shows how Sinovac Biotech Ltd's Strategic Asset Allocation Index has evolved across 22 annual periods from 2002 to 2023. As of June 2024, the index stands at 5.9%, representing strategic assets of $681.35 Million against net assets of $11.51 Billion USD. Explore Sinovac Biotech Ltd (SVA) cash conversion ratio to assess how effectively this company generates cash.
Annual Strategic Asset Allocation Index for Sinovac Biotech Ltd (2002–2023)
The table below presents the year-by-year Strategic Asset Allocation Index for Sinovac Biotech Ltd from 2002 to 2023, covering 22 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see SVA market cap.
| Year | SAAI | Strategic Assets (USD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2023 | 5.7% | $684.28 Million | $- | $684.28 Million | $12.02 Billion | ▲ +0.5 pp |
| 2022 | 5.2% | $661.44 Million | $- | $661.44 Million | $12.71 Billion | ▲ +0.5 pp |
| 2021 | 4.7% | $655.84 Million | $- | $655.84 Million | $13.88 Billion | ▼ -20.6 pp |
| 2020 | 25.4% | $284.20 Million | $284.20 Million | $0.00 | $1.12 Billion | ▲ +2.4 pp |
| 2019 | 23.0% | $80.95 Million | $80.95 Million | $- | $352.19 Million | ▼ -1.3 pp |
| 2018 | 24.3% | $70.92 Million | $70.92 Million | $0.00 | $291.93 Million | ▼ -34.7 pp |
| 2017 | 58.9% | $76.43 Million | $76.43 Million | $0.00 | $129.67 Million | ▲ +7.4 pp |
| 2016 | 51.6% | $66.88 Million | $66.88 Million | $0.00 | $129.67 Million | ▲ +4.8 pp |
| 2015 | 46.8% | $63.91 Million | $63.91 Million | $0.00 | $136.50 Million | ▼ -1.5 pp |
| 2014 | 48.3% | $68.42 Million | $68.42 Million | $- | $141.73 Million | ▲ +1.0 pp |
| 2013 | 47.3% | $67.96 Million | $67.96 Million | $- | $143.64 Million | ▼ -14.6 pp |
| 2012 | 61.9% | $80.08 Million | $80.08 Million | $- | $129.44 Million | ▲ +9.8 pp |
| 2011 | 52.1% | $75.63 Million | $75.63 Million | $- | $145.30 Million | ▲ +8.7 pp |
| 2010 | 43.3% | $64.04 Million | $64.04 Million | $- | $147.76 Million | ▲ +16.9 pp |
| 2009 | 26.4% | $22.31 Million | $22.31 Million | $- | $84.47 Million | ▼ -9.5 pp |
| 2008 | 35.9% | $19.26 Million | $19.26 Million | $- | $53.64 Million | ▼ -12.3 pp |
| 2007 | 48.3% | $15.88 Million | $15.88 Million | $- | $32.90 Million | ▼ -12.9 pp |
| 2006 | 61.1% | $13.03 Million | $13.03 Million | $- | $21.31 Million | ▼ -14.3 pp |
| 2005 | 75.5% | $12.46 Million | $12.46 Million | $- | $16.51 Million | ▲ +10.9 pp |
| 2004 | 64.5% | $10.04 Million | $10.04 Million | $- | $15.56 Million | ▼ -4.0 pp |
| 2003 | 68.5% | $7.46 Million | $7.46 Million | $- | $10.89 Million | ▲ +61.5 pp |
| 2002 | 7.0% | $7.00K | $7.00K | $- | $99.44K | — |